Tilray Brands reported record fiscal 2027 first-quarter net revenue of $257.1 million, up 23% from $209.5 million in the prior-year period.
Gross profit increased 35% to a record $77.5 million.
Gross margin expanded to 30% from 27%.
Tilray’s beverage business generated $101.5 million in revenue, up 82%, reflecting the BrewDog acquisition.
Beverage gross profit increased to $42 million, while gross margin expanded to 41%.
Distribution revenue increased 14% to $84.3 million.
Cannabis revenue was $56.1 million compared with $64.5 million a year earlier, while cannabis gross margin increased to 39% from 36%.
Wellness revenue remained approximately flat at $15.3 million.
Tilray reported a net loss of $40 million, or $0.32 per share, driven largely by non-cash charges.
Adjusted net loss was $3 million, or $0.02 per share.
Adjusted EBITDA totaled $9.2 million compared with $10.2 million a year earlier and included approximately $1.7 million of global fuel surcharges.
Tilray ended the quarter with $221.4 million of cash, restricted cash, and marketable securities.
The company reduced total outstanding debt by $42 million year-to-date and ended the quarter with a net cash position.
International momentum remained a major growth driver, with EMEA revenue increasing 71%.
Tilray reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million.
KEY QUOTES:
“Tilray’s record first-quarter revenue and gross profit demonstrate the power of the diversified platform we have built and the momentum we are creating across cannabis, beverage, hospitality, wellness and pharmaceutical distribution.”
Irwin D. Simon, Chairman and CEO of Tilray Brands
“We are no longer dependent on a single market or regulatory catalyst. We have multiple engines of growth, a scaled international footprint and the ability to convert scale into stronger margins, greater efficiency and sustainable, profitable growth.”
Irwin D. Simon, Chairman and CEO of Tilray Brands
